Últimas noticias sobre enVVeno Medical (NASDAQ:NVNO) Bolsa

enVVeno Medical

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

enVVeno Medical Corporation - Common Stock

enVVeno Medical Corp

Natera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) has outperformed the market over the past 5 years by 19.34% on an annualized basis producing an average annual return of 33.37%. Currently, Natera has a market capitalization of $20.02 billion. 
Buying $100 In NTRA: If an investor had bought $100 of NTRA stock 5 years ago, it would be worth $423.33 today based on a price of $148.08 for NTRA at the time of writing.
<h3>Natera's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744926311_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

NTRA

Here's How Much $100 Invested In Natera 5 Years Ago Would Be Worth Today

Enterprise Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBTC#NASDAQ">EBTC</a>) reported quarterly earnings of $0.84 per share. This is a 21.74 percent increase over earnings of $0.69 per share from the same period last year.

Earnings

EBTC

Enterprise Bancorp Q1 EPS $0.84 Up From $0.69 YoY

WKEY

WISeKey FY24 EPS $(0.39) Up From $(0.51) YoY; Revenue $11.875M Down From $30.918M YoY

BV Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVFL#NASDAQ">BVFL</a>) reported quarterly earnings of $0.21 per share. This is a 12.5 percent decrease over earnings of $0.24 per share from the same period last year.

BVFL

BV Financial Q1 EPS $0.21 Down From $0.24 YoY

United Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBFO#NASDAQ">UBFO</a>) reported quarterly earnings of $0.16 per share. This is a 33.33 percent decrease over earnings of $0.24 per share from the same period last year. The company reported $13.66 million in sales this quarter. This is a 6.96 percent increase over sales of $12.77 million the same period last year.

UBFO

United Security Q1 EPS $0.16 Down From $0.24 YoY, Sales $13.66M Up From $12.77M YoY

Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) has outperformed the market over the past 10 years by 2.96% on an annualized basis producing an average annual return of 12.55%. Currently, Danaher has a market capitalization of $133.67 billion. 
Buying $100 In DHR: If an investor had bought $100 of DHR stock 10 years ago, it would be worth $326.41 today based on a price of $186.83 for DHR at the time of writing.
<h3>Danaher's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744925426_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today

After years of struggling, discount retailing giant Dollar Tree Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) could be crafting a genuine comeback story. What's more, it's not just empty words. Serious money is flowing into DLTR stock, both in the open market as well as in the options arena, implying that the rally still has legs.
The most conspicuous clue that the turnaround may be genuine comes courtesy of Stewart Glendinning, Dollar Tree's chief financial officer. Recently, the executive <a href="https://www.benzinga.com/quote/DLTR/insider-trades">bought 17,000 shares of DLTR stock</a> at a per-share price of $72.75, a transaction size totaling $1.24 million. Glendinning <a href="https://www.benzinga.com/analyst-ratings/price-target/25/03/44474568/top-wall-street-forecasters-revamp-dollar-tree-price-expectations-ahead-of-q4-earnings">succeeded</a> former CFO Jeff Davis on March 30, who previously announced plans to step down. Fundamentally, the move is a quick way to ingratiate oneself into a new role or environment.
In addition, the transaction makes for unambiguous optics. Sure, the selling of one's own company doesn't necessarily inspire confidence. At the same time, people sell securities for all kinds of reasons, many of them mundane, such as for tax purposes. It's difficult to read into these sales without deeper context.
For insider buys? It's a straightforward interpretation: the security in question is perceived to eventually rise in value.
Even better, the insider buy doesn't appear to be mere grandstanding. Amid pressure from the Trump administration's trade war, retailers have been under the gun. Nevertheless, Dollar Tree could be ideally positioned, relatively speaking.
First, management stated that tariffs typically take three to four months to impact store inventory, providing a financial buffer. Second, the company's pricing and cost strategies can help maintain strong value offerings, according to Goldman Sachs analyst Kate McShane.
Combined with occupying practically the lowest rung of the trade-down effect — or the purchase of less expensive product alternatives — enthusiasm for Dollar Tree may be fundamentally justified.
<h2 class="wp-block-heading">Unusual Options Activity Sweeps into DLTR Stock</h2>
While it's always nice to see strong insider buys, it's even more encouraging when the transactions align with outside trading activity. Earlier on Thursday, Benzinga's <a href="https://www.benzinga.com/insights/options/25/04/44867614/spotlight-on-dollar-tree-analyzing-the-surge-in-options-activity">options scanner</a> identified several bullish transactions, particularly call options with an $80 strike price. Since the market tends to gravitate toward round numbers — acting as psychological magnets for various order levels — the technical pull could be stronger than normal.
Of course, every day, calls and puts are being sold for major securities. Two factors, though, bring significant intrigue into the above equation. First, one of the $80 calls — which expires on May 2 — was a sweep transaction. Sweeps represent large trades that split across multiple exchanges simultaneously. Primarily, the takeaway here is speed over price. It's basically the institutional version of a market order.
Second, the volume of the sweep calls greatly exceeded the open interest reading. While it's not 100% for certain, generally speaking, a higher volume count relative to open interest suggests that new positions are being opened. In other words, there appears to be real demand undergirding these DLTR stock call options, rather than just hedging noise.
Moreover, as a sweep transaction prioritizing speed, the premium paid for the $80 calls — the ask price of $1.44 — must be reflected into the equation. Because buying calls represents a debit transaction, at expiration, DLTR stock must be worth $81.44 to break even. It's possible, then, that DLTR could pop even higher than $80.
<h2 class="wp-block-heading">Setting Up a Bullish Dollar Tree Options Strategy</h2>
For traders looking for a quick score, the 78/80 bull call spread expiring May 2 could be an interesting proposition. This transaction involves buying the $78 call (at a time-of-writing ask of $365) and simultaneously selling the $80 call (at a bid of $240), resulting in a net debit paid of $125. Should DLTR stock hit the $80 short strike at expiration, the maximum reward is $75, or a 60% payout.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17152303/DLTR-stock-probability-gambit-1024x576.jpg" alt="" class="wp-image-877591" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17152303/DLTR-stock-probability-gambit-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17152303/DLTR-stock-probability-gambit-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17152303/DLTR-stock-probability-gambit-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17152303/DLTR-stock-probability-gambit.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Statistically, DLTR stock enjoys a slight upward bias for a baseline three-week hold; that is, for any given three-week period, the odds of profitability favor the bulls. It's also worth mentioning that DLTR has thrived on prior momentum. Whenever the prior week saw a return of 5% to 10%, the subsequent eight weeks forward have seen a noticeable lift in long-side odds.
That said, while the likelihood of a positive price action appears elevated, investors shouldn't expect dramatic price gains. As such, the most aggressive short leg strike price for the May 2 expiration date should be $81.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44875406/hell-be-out-if-i-ask-him-can-trumps-threat-to-oust-powell-shake-the-fed">&#8216;He&#8217;ll Be Out&#8230; If I Ask Him&#8217;: Can Trump&#8217;s Threat To Oust Powell Shake The Fed?</a></li>
</ul>
Photo: Aaron of L.A. Photography/Shutterstock

DLTR

Options Corner: Why The Big Bettors Say Dollar Tree Has More Value To Unlock

Minerals Technologies Preliminary Q1 Results; Expects $492M Sales Results

Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) has outperformed the market over the past 10 years by 3.77% on an annualized basis producing an average annual return of 13.36%. Currently, Marvell Tech has a market capitalization of $44.78 billion. 
Buying $100 In MRVL: If an investor had bought $100 of MRVL stock 10 years ago, it would be worth $346.05 today based on a price of $51.70 for MRVL at the time of writing.
<h3>Marvell Tech's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744924532_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MRVL

$100 Invested In Marvell Tech 10 Years Ago Would Be Worth This Much Today

Roku Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) shares are rising in extended trading Thursday following strong advertising trends from Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>), which reported blowout results for the <a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering">first quarter after the bell</a>.
Netflix Q1 Results: Netflix reported first-quarter revenue of $11.04 billion, beating analyst estimates of $10.9 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The streaming giant reported adjusted earnings of $7.03 per share, beating estimates of $6.27 per share. 
Total revenue was up 13% year-over-year, driven by membership growth and higher pricing. The company said results came in above company expectations due to higher-than-forecasted subscription and ad revenue. Netflix guided for 15% revenue growth in the second quarter, citing continued strong trends in memberships and advertising revenue. 
&#8220;A key focus in 2025 is enhancing our capabilities for advertisers. We successfully rolled out the Netflix Ads Suite, our in house first party ad tech platform, in the U.S. on April 1st. In the coming months we will launch the Netflix Ads Suite in our remaining ads markets. We believe our ad tech platform is foundational to our long-term ads strategy,&#8221; the company said in a letter to shareholders.
Everything You Need To Know: <a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering">Netflix Crushes Q1, Says It&#8217;s &#8216;Working Hard To Improve And Expand&#8217; Its Offering</a>
Why It Matters: Roku is well-positioned to benefit from strong advertising trends. The company focuses on revenue opportunities with streaming companies through partnerships and advertising. 
Netflix was reportedly&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/06/27622300/3-reasons-why-this-analyst-thinks-a-netflix-roku-deal-may-not-materialize" target="_blank" rel="noreferrer noopener">considering a takeover of Roku</a>&nbsp;a few years ago, but a deal never materialized. Roku operates an advertising distribution platform, allowing it to capitalize on the growth of streaming. 
Roku on Thursday announced it will report first-quarter earnings on May 1. Analysts are anticipating a loss of 27 cents per share and revenue of $1.01 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Last quarter, Roku shares surged after the company reported better-than-expected results and crossed $1 billion in Platform revenue for the first time. 
&#8220;In&nbsp;Q4, Streaming Hours on The Roku Channel grew&nbsp;82%&nbsp;YoY, and in the U.S. it reached households with approximately 145 million people," the company said at the time. &#8220;We also continue to expand our penetration in the U.S., which has surpassed half of broadband households.&#8221;
ROKU Price Action: Roku shares initially popped about 2.5% following Netflix&#8217;s results. The stock was up 0.92% after-hours, trading at $59 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/content/44861194/disney-how-the-fubo-sports-deal-became-a-game-changer">Disney: How the Fubo Sports Deal Became a Game Changer</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/tadaimages">Tada Images</a>/Shutterstock.

After-Hours Center

Movers

Media

NFLX

ROKU

Roku Stock Moves Higher Following Netflix Q1 Earnings: What You Need To Know

General

PCRX

Pacira BioSciences Announces $300M Share Repurchase Program

Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) is ramping up its <a href="https://www.benzinga.com/news/earnings/24/07/39801252/bofa-manages-to-keep-expenses-in-check-by-going-digital-now-the-bank-is-using-ai-to-take-it-to-anot">investment in artificial intelligence</a>, planning to spend $4 billion on AI initiatives over the next year—nearly a third of its annual $13 billion tech budget.
The company <a href="https://newsroom.bankofamerica.com/content/newsroom/press-releases/2025/04/ai-adoption-by-bofa-s-global-workforce-improves-productivity--cl.html">disclosed</a> the figure in a recent release, noting that both internal and customer-facing tools are already showing strong returns, ranging from cost reductions to improved user experiences.
Benzinga reached out to Bank of America for more details, but the bank was unable to comment by the time of publication. That being said, there are many interesting tidbits to highlight in the press release itself.
Among major U.S. banks, Bank of America appears to be leading the charge in deploying AI at scale. Its consumer chatbot Erica—launched seven years ago—has handled over 2.5 billion interactions and now serves 20 million active users. Meanwhile, sibling products like askMerrill and askPrivate Banking saw more than 23 million interactions in 2024, up by over a million from the previous year.
<h3 class="wp-block-heading">Enterprise AI Is Catching Up Fast</h3>
While consumer-facing AI has been in place for years, BofA's enterprise AI rollout is more recent—and more ambitious. New internal data reveals just how widely the bank is applying generative AI across its operations:
<ul>
<li>Internal Support (IT): Erica for Employees, an internal AI chatbot adapted from the public-facing version, is now used by over 90% of BofA's 213,000 employees—reducing IT help desk requests by more than 50%.</li>
<li>Developer Productivity: Engineers using generative AI coding assistants are seeing up to 20% improvements in productivity, helping them move faster across technical workflows.</li>
<li>Meeting Preparation: AI is helping employees generate meeting prep materials for client engagements, saving tens of thousands of hours annually—time that's redirected toward client-facing work.</li>
<li>Customer Support: Contact center agents use AI tools to deliver faster, more personalized service, which has reduced average call times.</li>
<li>Research Access (Sales &amp; Trading): Sales and trading teams use a homegrown generative AI tool to summarize BofA research and market updates more efficiently, helping them move quickly in volatile markets.</li>
</ul>
<h3 class="wp-block-heading">Why This Matters</h3>
Other institutions like JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), and Citigroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) are also building AI-powered tools for employees and customers. But Bank of America stands out for its transparency and measurable results.
Cutting IT support demand in half, improving developer velocity, and enhancing customer satisfaction are all indicators that this isn't hype—it's execution.
And yet, this is just the beginning. The generative AI transformation in banking is still in its early innings. What we're seeing now is likely just a preview of how financial services will operate in the next decade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44878275/billionare-investor-bill-ackman-posts-hertz-investment-thesis-proposes-av-fleet-partnership-with-uber">Billionare Investor Bill Ackman Posts Hertz Investment Thesis, Proposes AV Fleet Partnership With Uber</a></li>
</ul>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Tech

Bank Of America Bets Big On AI With $4 Billion Investment—And It's Already Paying Off

NRGV

Energy Vault Holdings Receives Notice Regarding Continued Listing Standards From NYSE

<h3>Gainers</h3>
<ul>
<li>BitFuFu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) stock rose 17.1% to $5.05 during Thursday's after-market session. The market value of their outstanding shares is at $822.6 million. </li>
<li>Iveda Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVDA#NASDAQ">IVDA</a>) stock increased by 6.19% to $2.57. The market value of their outstanding shares is at $6.8 million. The company's, Q4 earnings came out 2 days ago. </li>
<li>Soluna Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNH#NASDAQ">SLNH</a>) shares increased by 5.06% to $0.65. The market value of their outstanding shares is at $6.8 million. </li>
<li>SkyWater Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) shares rose 4.85% to $6.91. The market value of their outstanding shares is at $331.6 million. </li>
<li>NOVONIX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVX#NASDAQ">NVX</a>) shares increased by 4.23% to $1.23. The market value of their outstanding shares is at $195.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fatpipe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATN#NASDAQ">FATN</a>) stock declined by 8.4% to $11.38 during Thursday's after-market session. The company's market cap stands at $156.1 million. </li>
<li>Smith Micro Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMSI#NASDAQ">SMSI</a>) shares declined by 6.48% to $0.86. The market value of their outstanding shares is at $15.2 million. </li>
<li>DoubleVerify Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) shares decreased by 5.29% to $11.82. The company's market cap stands at $1.9 billion. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock declined by 5.0% to $0.66. The company's market cap stands at $2.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock declined by 4.91% to $1.94. The company's market cap stands at $1.1 million. </li>
<li>XIAO-I (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIXI#NASDAQ">AIXI</a>) shares fell 4.07% to $2.83. The market value of their outstanding shares is at $29.8 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIXI

FATN

FUFU

IVDA

Nuveen California Dividend Advantage Municipal Fund 2

PRSO

SKYT

SLNH

SMSI

SVRE

11 Information Technology Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) stock rose 9.6% to $0.8 during Thursday's after-market session. The market value of their outstanding shares is at $6.9 million. </li>
<li>Mixed Martial Arts Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) shares rose 7.51% to $1.0. The company's market cap stands at $10.4 million. </li>
<li>Gogoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GGR#NASDAQ">GGR</a>) stock moved upwards by 7.5% to $0.31. The market value of their outstanding shares is at $90.4 million. </li>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) shares increased by 7.47% to $0.15. The market value of their outstanding shares is at $7.3 million. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) stock moved upwards by 7.16% to $0.83. </li>
<li>Birks Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) stock increased by 6.7% to $0.94. The market value of their outstanding shares is at $18.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lixiang Education Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) shares declined by 25.7% to $5.08 during Thursday's after-market session. The market value of their outstanding shares is at $5.9 million. </li>
<li>Kaixin Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) stock fell 8.41% to $1.09. The market value of their outstanding shares is at $1.9 million. </li>
<li>Mingteng International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEN#NASDAQ">MTEN</a>) shares declined by 5.22% to $4.0. The company's market cap stands at $27.3 million. </li>
<li>MEDIROM Healthcare Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRM#NASDAQ">MRM</a>) stock declined by 5.19% to $0.75. The market value of their outstanding shares is at $5.9 million. </li>
<li>Foresight Autonomous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) stock decreased by 5.14% to $0.6. The market value of their outstanding shares is at $11.3 million. </li>
<li>Jiuzi Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) stock fell 4.92% to $6.38. The company's market cap stands at $70.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIEV

FRSX

JZXN

KXIN

LOBO

LXEH

MTEN

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Direct Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRCT#NASDAQ">DRCT</a>) shares moved upwards by 51.6% to $0.97 during Thursday's after-market session. The company's market cap stands at $18.3 million. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) stock moved upwards by 17.64% to $2.0. The market value of their outstanding shares is at $3.0 million. </li>
<li>Intelligent Protection (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPM#NASDAQ">IPM</a>) shares rose 7.18% to $1.79. The market value of their outstanding shares is at $16.5 million. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) stock moved upwards by 5.3% to $2.98. The company's market cap stands at $4.8 million. </li>
<li>AirNet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANTE#NASDAQ">ANTE</a>) shares moved upwards by 4.72% to $0.78. The company's market cap stands at $11.1 million. </li>
<li>BloomZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) shares increased by 4.47% to $0.15. The market value of their outstanding shares is at $2.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) stock fell 6.4% to $0.22 during Thursday's after-market session. The market value of their outstanding shares is at $3.7 million. </li>
<li>Cumulus Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMLS#NASDAQ">CMLS</a>) stock decreased by 5.01% to $0.24. The market value of their outstanding shares is at $4.0 million. </li>
<li>Liberty Latin America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILAK#NASDAQ">LILAK</a>) stock declined by 4.67% to $5.11. The company's market cap stands at $1.0 billion. </li>
<li>Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) shares declined by 4.63% to $2.62. The market value of their outstanding shares is at $8.3 million. </li>
<li>Liberty Latin America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILA#NASDAQ">LILA</a>) stock fell 4.11% to $5.14. The company's market cap stands at $1.0 billion. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) shares fell 3.64% to $0.56. The company's market cap stands at $5.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANTE

BAOS

BLMZ

CMLS

DRCT

LILA

LILAK

MITQ

MSGM

12 Communication Services Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Forian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORA#NASDAQ">FORA</a>) shares rose 53.5% to $3.0 during Thursday's after-market session. The company's market cap stands at $93.5 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares increased by 17.85% to $10.43. The market value of their outstanding shares is at $65.8 million. </li>
<li>Adicet Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACET#NASDAQ">ACET</a>) shares moved upwards by 10.23% to $0.58. The company's market cap stands at $47.9 million. </li>
<li>Syra Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRA#NASDAQ">SYRA</a>) stock moved upwards by 9.02% to $0.11. The company's market cap stands at $1.3 million. </li>
<li>Ernexa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares moved upwards by 7.51% to $0.2. The market value of their outstanding shares is at $10.3 million. </li>
<li>X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) shares rose 7.44% to $0.2. The company's market cap stands at $35.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Adagio Medical Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADGM#NASDAQ">ADGM</a>) shares decreased by 13.5% to $1.54 during Thursday's after-market session. The market value of their outstanding shares is at $23.8 million. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) shares declined by 9.96% to $1.9. The company's market cap stands at $26.1 million. </li>
<li>Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) shares decreased by 6.97% to $0.8. The company's market cap stands at $60.6 million. </li>
<li>Sensei Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNSE#NASDAQ">SNSE</a>) shares decreased by 6.03% to $0.39. The market value of their outstanding shares is at $9.8 million. </li>
<li>Soleno Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) shares decreased by 5.69% to $66.0. The market value of their outstanding shares is at $2.8 billion. </li>
<li>Hoth Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) stock decreased by 5.59% to $0.75. The market value of their outstanding shares is at $9.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACET

ADGM

CLSD

ERNA

FORA

HOTH

SLNO

SNSE

SXTC

SYRA

XCUR

XFOR

12 Health Care Stocks Moving In Thursday's After-Market Session

Motorsport Games Achieves Compliance With Nasdaq Listing Standards

Stock Split

FOXO

Foxo Technologies Announces 1 For 10 Reverse Stock Split, Effective April 28, 2025

Zoom Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) shares are trading higher Thursday following a significant global outage that temporarily disabled key parts of Zoom's platform, including video calls,<a href="https://www.benzinga.com/quote/ZM/news"> its web portal and app.</a>
What To Know: The outage, which occurred on Wednesday afternoon, was confirmed by the company and tracked in real time by Downdetector.com, according to Reuters. At its peak, over 67,000 users reported problems accessing Zoom&#8217;s services, with disruptions affecting both U.S. and international users. The company did not offer a detailed technical explanation but confirmed on social media that full service had been restored.
The brief disruption likely reminded investors of the platform's broad user base and the technical risks that come with operating such a widely used service. But, the lack of a sharp sell-off suggests the market viewed the outage as temporary and not materially damaging to Zoom&#8217;s longer-term operations or reputation. Still, a repeat of such widespread failures could draw more scrutiny given how reliant businesses, schools and government agencies have become on Zoom for communication.
<h1 class="wp-block-heading">Will Zoom Shares Go Up?</h1>
When trying to assess whether or not Zoom will trade higher from current levels, it's a good idea to take a look at analyst forecasts.
Wall Street analysts have an average 12 month price target of $85.25 on Zoom. The &#8220;Street high&#8221; target is currently at $97 and the &#8220;Street low&#8221; target is $7. Of all the analysts covering Zoom Communications, five have positive ratings, seven have neutral ratings and none have negative ratings.
In the last month, four analysts have adjusted price targets. Here's a look at recent price target changes <a href="https://www.benzinga.com/quote/ZM/analyst-ratings">[Analyst Ratings]</a>. Benzinga also tracks Wall Street's most accurate analysts. Check out how analysts covering Zoom have performed in recent history.
Stocks don't move in a straight line. The average stock market return is approximately 10% per year. Zoom is down 12.37% year-to-date. The average analyst price target suggests the stock could have further upside ahead.
For a broad overview of everything you need to know about Zoom, visit <a href="https://www.benzinga.com/quote/ZM">here</a>. If you want to go above and beyond, there's no better tool to help you do just that than <a href="https://pro.benzinga.com/">Benzinga Pro</a>. Start your free trial today.
ZM Price Action: Zoom shares closed Thursday up 0.41% at $71.49 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0417"><img loading="lazy" decoding="async" width="1024" height="566" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17163518/Screenshot-2025-04-17-at-16.33.21-1024x566.png" alt="" class="wp-image-877718" style="width:425px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17163518/Screenshot-2025-04-17-at-16.33.21-1024x566.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17163518/Screenshot-2025-04-17-at-16.33.21-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17163518/Screenshot-2025-04-17-at-16.33.21-768x425.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/17163518/Screenshot-2025-04-17-at-16.33.21.png 1457w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/04/44875406/hell-be-out-if-i-ask-him-can-trumps-threat-to-oust-powell-shake-the-fed">&#8216;He&#8217;ll Be Out&#8230; If I Ask Him&#8217;: Can Trump&#8217;s Threat To Oust Powell Shake The Fed?</a></li>
</ul>
Photo: Shutterstock.

What's Going On With Zoom Shares Today?

Biotech

Events

Press Releases

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe

Interim Two-Year Follow-Up Data from the VenoValve(R) U.S. Pivotal Trial to be Presented Today at the VESS 2025 Annual Winter Meeting

One-Year Data from the VenoValve(R) U.S. Pivotal Trial Highlighting Impact on Patients' Quality of Life (QOL) to be Presented Today at the 37th Annual Meeting of the American Venous Forum

Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand

enVVeno Medical Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25

The Impact of the VenoValve(R) on Patients with Primary and Secondary Chronic Venous Insufficiency (CVI) to be Presented at the Society for Clinical Vascular Surgery 52nd Annual Symposium

enVVeno Medical to Participate in a Live Virtual Investor Closing Bell Segment

AKTX

AMIX

AREC

CNSP

HURA

NVNO

OTLK

PALI

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

HeartBeam

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

CytoSorbents

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

enVVeno Medical

Noticias

Últimas noticias sobre enVVeno Medical (NASDAQ:NVNO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL